Treatment of Chronic Infections with Rifamycins: Is Resistance Likely To Follow?
- 1 October 2003
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (10) , 3037-9
- https://doi.org/10.1128/aac.47.10.3037-3039.2003
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South AfricaAIDS, 2003
- Development potential of rifalazilExpert Opinion on Investigational Drugs, 2003
- Rapid Detection of Rifampin Resistance in Mycobacterium tuberculosis Isolates by Heteroduplex Analysis and Determination of Rifamycin Cross-Resistance in Rifampin-Resistant IsolatesJournal of Clinical Microbiology, 2003
- Tuberculosis Drug Resistance: A Global ThreatClinical Infectious Diseases, 2003
- Serum Cytokine Concentrations Do Not ParallelMycobacterium tuberculosis–Induced Cytokine Production in Patients with TuberculosisClinical Infectious Diseases, 2003
- SHORT-COURSE CHEMOPROPHYLAXIS FOR TUBERCULOSISClinics in Chest Medicine, 1997
- Treatment of Multidrug-Resistant TuberculosisNew England Journal of Medicine, 1993
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993
- Studies of case-finding for pulmonary tuberculosis in outpatients at 4 district hospitals in KenyaTubercle, 1985
- THE TUBERCLE BACILLUS IN THE PULMONARY LESION OF MANThe Lancet Healthy Longevity, 1956